Panaxia Pharmaceutical Industries Revenue and Competitors
Estimated Revenue & Valuation
- Panaxia Pharmaceutical Industries's estimated annual revenue is currently $22.7M per year.
- Panaxia Pharmaceutical Industries's estimated revenue per employee is $270,000
Employee Data
- Panaxia Pharmaceutical Industries has 84 Employees.
- Panaxia Pharmaceutical Industries grew their employee count by -16% last year.
Panaxia Pharmaceutical Industries's People
Name | Title | Email/Phone |
---|---|---|
1 | Finance Manager | Reveal Email/Phone |
2 | Financial Controller | Reveal Email/Phone |
3 | PM Panaxia Logistics | Reveal Email/Phone |
4 | Medical Expert | Reveal Email/Phone |
Panaxia Pharmaceutical Industries Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $27.5M | 102 | -30% | N/A | N/A |
#2 | $43.2M | 149 | 12% | $70M | N/A |
#3 | $22.7M | 84 | -16% | N/A | N/A |
What Is Panaxia Pharmaceutical Industries?
Panaxia is a pharmaceutical company specializing in medical cannabis R&D and manufacturing. We are bringing scientific rigor and pharmaceutical manufacturing standards to the rapidly evolving field of medical cannabis. As a leader in this category, Panaxia is spearheading the adoption of cannabis-based treatments by developing consistent, effective, high-quality products that can be taken through a variety of familiar delivery methods to substantially improve the lives of people with a wide range of medical conditions. We offer over 65 different products, all manufactured under extremely stringent Good Manufacturing Practice (GMP) guidelines and with the most advanced analytical and validation methods to meet the most demanding requirements for consistency and dosage accuracy. Panaxia is part of a group of leading Israeli pharmaceutical companies with more than four decades of experience and proven success. We invest substantially in research and development and have clinical partnerships with prominent medical centers. Operating around the globe, our network is extensive and ever growing. Collaborating with the world?s best medical cannabis companies and organizations enables us to bring cannabis products of the highest quality and consistency to as many people as possible.
keywords:N/AN/A
Total Funding
84
Number of Employees
$22.7M
Revenue (est)
-16%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Panaxia Pharmaceutical Industries News
Panaxia sums up 2021 with a growth of 38% in total revenues of its ... PR Newswire
LOD, Israel, Sept. 2, 2021 /PRNewswire/ -- The Israeli subsidiary of Panaxia Global, Panaxia Labs Israel Ltd. ("Panaxia Israel"), (TASE: PNAX), a global pharma company that develops, manufactures and markets progressive medical cannabis products in pharmaceutical quality, published today its fin ...
LOD, Israel, June 1, 2021 /PRNewswire/ -- The Israeli subsidiary of Panaxia Global, Panaxia Labs Israel Ltd. ("Panaxia Israel") (TASE: PNAX), Israel's largest medical cannabis company and a global company with activity in Germany, France, Israel, Cyprus, Greece and Malta, today published its fin ...
ATHENS and TEL AVIV, Israel, May 19, 2021 /PRNewswire/ -- Panaxia Labs Israel, Ltd. (Panaxia Israel) (TASE: PNAX), Israel's leading medical cannabis products manufacturer and Leriva Group, one of Greece's leading distributors of medical equipment, medical supplies and health services, announced ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.5M | 106 | -5% | N/A |
#2 | $17.1M | 118 | 17% | N/A |
#3 | $154.8M | 381 | 8% | N/A |
#4 | $241.5M | 1402 | 1% | $91M |